Clifford Chance has advised CITIC Securities as financial adviser to Sinopharm Common Wealth Company Limited. Sinopharm Common Wealth Company Limited, an investment consortium led by Sinopharm...
Sinopharm Group’s HK$15.6 Billion Privatization Of China TCM
Isola Castle Ltd’s Acquisition of Vinda Shares From Essity AB
Clifford Chance advised Essity AB on the deal. Linklaters acted for Royal Golden Eagle. Isola Castle Ltd, a company indirectly wholly owned by Asia Pacific Resources...
Stellantis’ €1.5 Billion Investment in Zhejiang Leapmotor Technology Co., Ltd.
Clifford Chance has advised Zhejiang Leapmotor Technology Co., Ltd. on the deal. Stellantis N.V. plans to invest ca. €1.5 billion to acquire approximately 20% of Leapmotor, making...
Red Star Macalline Holding’s US$938 Million Sale of 29.95% Stake in Red Star Macalline Group Corporation Ltd.
Clifford Chance advises Red Star Macalline Holding on the RMB6.3 billion sale of a 29.95% equity interest in Red Star Macalline Group Corporation to Xiamen C&D....
Jin Jiang Capital’s Privatization
Baker McKenzie FenXun and Clifford Chance advised Jin Jiang International Holding Company Limited on the deal. Ashurst represented Orient Capital (Hong Kong) Limited and Nomura International...